Modes and consequences of thrombin's interaction with fibrin

Biophysical Chemistry

Volumn 112, Issue 2-3 SPEC. ISS., 2004, Pages 277-284

  Fredenburgh, James C ^a   Stafford, Alan R ^a   Pospisil, Caroline H ^a   Weitz, Jeffrey I ^a  

^a HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Exosite; Fibrin; Fibrinogen; Heparin; Thrombin; Thrombosis

Indexed keywords

ANTITHROMBIN; COAGULATING AGENT; FIBRIN; FIBRINOLYTIC AGENT; PROCOAGULANT; THROMBIN; THROMBIN INHIBITOR; THROMBOMODULIN;

ARTERY THROMBOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOCHEMISTRY; BLEEDING; CELL ACTIVITY; CIRCULATION; ENDOTHELIUM; PATHOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; VEIN THROMBOSIS;

FIBRIN; HEMOSTASIS; HUMANS; PROTEIN BINDING; THROMBIN; THROMBOSIS;

THROMBUS;

EID: 9644253005     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpc.2004.07.031     Document Type: Article

References (63)

1. E. Di Cera Thrombin interactions Chest 124 2003 11S 17S
2. L. Hedstrom Serine protease mechanism and specificity Chem. Rev. 102 2002 4501 4524
3. B. Furie, D.H. Bing, R.J. Feldmann, D.J. Robison, J.P. Burnier, and B.C. Furie Computer-generated models of blood coagulation factor Xa, factor IXa, and thrombin based upon structural homology with other serine proteases J. Biol. Chem. 257 1982 3875 38821
4. W. Bode, D. Turk, and A. Karshikov The refined 1.9 A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active site geometry, and structure-function relationships Protein Sci. 1 1992 426 471
5. R. De Cristofaro, and E. De Candia Thrombin domains: structure, function and interaction with platelet receptors J. Thromb. Thrombolysis 15 2003 151 163
6. C.T. Esmon Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface FASEB J. 9 1995 946 955
7. P. Fuentes-Prior, Y. Iwanaga, R. Huber, R. Pagila, G. Rumennik, M. Seto, J. Morser, D.R. Light, and W. Bode Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex Nature 404 2000 518 525
8. S.C. Bock Antithrombin III and heparin cofactor II R.W. Colman J. Hirsh V.J. Marder A.W. Clowes J.N. George Hemostasis and Thrombosis. Basic Principles and Clinical Practice 2001 Lippincott Williams and Wilkins Philadelphia 321 334
9. C.T. Esmon, and P. Lollar Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII J. Biol. Chem. 271 1996 13882 13887
10. T. Myles, T.H. Yun, and L.L. Leung Structural requirements for the activation of human factor VIII by thrombin Blood 100 2002 2820 2826
11. T. Myles, T.H. Yun, S.W. Hall, and L.L. Leung An extensive interaction interface between thrombin and factor V is required for factor V activation J. Biol. Chem. 276 2001 25143 25149
12. R.K. Arni, K. Padmanabhan, K.P. Padmanabhan, T.P. Wu, and A. Tulinsky Structures of noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin Biochemistry 32 1993 4727 4737
13. P.J. Hogg, C.M. Jackson, J.K. Labanowski, and P.E. Bock Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen J. Biol. Chem. 271 1996 26088 26095
14. J. Ye, N.L. Esmon, C.T. Esmon, and A.E. Johnson The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation J. Biol. Chem. 266 1991 23016 23021
15. K.R. Dharmawardana, S.T. Olson, and P.E. Bock Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments J. Biol. Chem. 274 1999 18635 18643
16. C.H. Pospisil, A.R. Stafford, J.C. Fredenburgh, and J.I. Weitz Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin J. Biol. Chem. 278 2003 21584 21591
17. J.C. Fredenburgh, A.R. Stafford, and J.I. Weitz Evidence for allosteric linkage between exosites 1 and 2 of thrombin J. Biol. Chem. 272 1997 25493 25499
18. L.W. Liu, J. Ye, A.E. Johnson, and C.T. Esmon Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site J. Biol. Chem. 266 1991 23632 23636
19. M.C. Naski, J.W.I. Fenton, J.M. Maraganore, S.T. Olson, and J.A. Shafer The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen J. Biol. Chem. 265 1990 13484 13489
20. P.J. Anderson, A. Nesset, and P.E. Bock Effects of activation peptide bond cleavage and fragment 2 interactions on the pathway of exosite I expression during activation of human prethrombin 1 to thrombin J. Biol. Chem. 278 2003 44482 44488
21. P.C.Y. Liaw, J.C. Fredenburgh, A.R. Stafford, A. Tulinsky, R.C. Austin, and J.I. Weitz Localization of the thrombin-binding domain on prothrombin fragment 2 J. Biol. Chem. 273 1998 8932 8939
22. K.G. Mann Thrombin: can't live without it; probably die from it Chest 124 2003 1S 3S
23. C.G. Binnie, and S.T. Lord The fibrinogen sequences that interact with thrombin Blood 81 1993 3186 3192
24. T. Rose, and E. Di Cera Three-dimensional modeling of thrombin-fibrinogen interaction J. Biol. Chem. 277 2002 18875 18880
25. M. Kaminski, and J. McDonagh Inhibited thrombins. Interactions with fibrinogen and fibrin Biochem. J. 242 1987 881 887
26. M.C. Naski, and J.A. Shafer Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin J. Biol. Chem. 265 1990 1401 1407
27. Z. Yang, J.M. Kollman, L. Pandi, and R.F. Doolittle Crystal structure of native chicken fibrinogen at 2.7 Å resolution Biochemistry 40 2001 12515 12523
28. K.R. Siebenlist, J.P. Di Orio, A.Z. Budzynski, and M.W. Mosesson The polymerization and thrombin-binding properties of des-(Bbeta1-42)-fibrin J. Biol. Chem. 265 1990 18650 18655
29. D.A. Meh, K.R. Siebenlist, and M.W. Mosesson Identification and characterization of the thrombin binding sites on fibrin J. Biol. Chem. 271 1996 23121 23125
30. M.W. Mosesson Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly Blood Coagul. Fibrinolysis 8 1997 257 267
31. D.A. Meh, M.W. Mosesson, K.R. Siebenlist, P.J. Simpson-Haidaris, S.O. Brennan, and J.P. Diorio Fibrinogen Naples I (B beta A68T) nonsubstrate thrombin-binding capacities Thromb. Res. 103 2001 63 73
32. J.A. Shafer, and D.L. Higgins Human fibrinogen CRC Crit. Rev. Clin. Lab. Sci. 26 1988 1 41
33. M.W. Mosesson Fibrinogen gamma chain functions J. Thromb. Haemost. 1 2003 231 238
34. D.A. Meh, K.R. Siebenlist, S.O. Brennan, T. Holyst, and M.W. Mosesson The amino acid sequence in fibrin responsible for high affinity thrombin binding Thromb. Haemost. 85 2001 470 474
35. R.S. Lovely, M. Moaddel, and D.H. Farrell Fibrinogen gamma′ chain binds thrombin exosite II J. Thromb. Haemost. 1 2003 124 131
36. J.W.I. Fenton, T.A. Olson, M.P. Zabinski, and G.D. Wilner Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition Biochemistry 27 1988 7106 7112
37. C.Y. Liu, H.L. Nossel, and K.L. Kaplan The binding of thrombin by fibrin J. Biol. Chem. 254 1979 10421 10425
38. J. Ye, A.R. Rezaie, and C.T. Esmon Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101 J. Biol. Chem. 269 1994 17965 17970
39. T. Myles, B.F. Le Bonniec, and S.R. Stone The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1 Eur. J. Biochem. 268 2001 70 77
40. S.W. Hall, C.S. Gibbs, and L.L. Leung Identification of critical residues on thrombin mediating its interaction with fibrin Thromb. Haemost. 86 2001 1466 1474
41. E. Skrzypczak-Jankun, V.E. Carperos, K.G. Ravichandran, A. Tulinsky, M. Westbrook, and J.M. Maraganore Structure of the hirugen and hirulog 1 complexes of alpha-thrombin J. Mol. Biol. 221 1991 1379 1393
42. T.J. Rydel, K.G. Ravichandran, A. Tulinsky, W. Bode, R. Huber, C. Roitsch, and J.W.I. Fenton The structure of a complex of recombinant hirudin and human alpha-thrombin Science 249 1990 277 280
43. P.J. Hogg, and P.E. Bock Modulation of thrombin and heparin activities by fibrin Thromb. Haemost. 77 1997 424 433
44. D.A. Meh, M.W. Mosesson, K.R. Siebenlist, P.J. Simpson-Haidaris, S.O. Brennan, and J.P. Diorio Fibrinogen Naples I (B beta A68T) nonsubstrate thrombin-binding capacities Thromb. Res. 103 2001 63 73
45. D.L. Becker, J.C. Fredenburgh, A.R. Stafford, and J.I. Weitz Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II J. Biol. Chem. 274 1999 6226 6233
46. I.M. Verhamme, S.T. Olson, D.M. Tollefsen, and P.E. Bock Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II J. Biol. Chem. 277 2002 6788 6798
47. J.I. Weitz, B. Leslie, and M. Hudoba Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors Circulation 97 1998 544 552
48. P.R. Eisenberg, and G. Ghigliotti Platelet-dependent and procoagulant mechanisms in arterial thrombosis Int. J. Cardiol. 68 Suppl. 1 1999 3 10
49. M.C. Bahit, C.B. Granger, and L. Wallentin Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment Am. Heart J. 143 2002 205 216
50. J.I. Weitz, and H.R. Buller Direct thrombin inhibitors in acute coronary syndromes: present and future Circulation 105 2002 1004 1011
51. A.L. Bloom The release of thrombin from fibrin by fibrinolysin Br. J. Haematol. 8 1962 129 133
52. N.J. Mutch, L.A. Robbie, and N.A. Booth Human thrombi contain an abundance of active thrombin Thromb. Haemost. 86 2001 1028 1034
53. J.I. Weitz, M. Hudoba, D. Massel, J. Maraganore, and J. Hirsh Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J. Clin. Invest. 86 1990 385 391
54. R. Kumar, S. Beguin, and H.C. Hemker The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity Thromb. Haemost. 74 1995 962 968
55. R. Kumar, S. Beguin, and H.C. Hemker The influence of fibrinogen and fibrin on thrombin generation-evidence for feedback activation of the clotting system by clot bound thrombin Thromb. Haemost. 72 1994 713 721
56. R.S. Lovely, L.A. Falls, H.A. Al Mondhiry, C.E. Chambers, G.J. Sexton, H. Ni, and D.H. Farrell Association of gammaA/gamma′ fibrinogen levels and coronary artery disease Thromb. Haemost. 88 2002 26 31
57. P.C.Y. Liaw, D.L. Becker, A.R. Stafford, J.C. Fredenburgh, and J.I. Weitz Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin J. Biol. Chem. 276 2001 20959 20965
58. P.J. Hogg, and C.M. Jackson Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex J. Biol. Chem. 265 1990 241 247
59. S. Yakovlev, S. Gorlatov, K. Ingham, and L. Medved Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site Biochemistry 42 2003 7709 7716
60. T. Odrljin, J.R. Shainoff, S.O. Lawrence, and P.J. Simpson-Haidaris Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain Blood 88 1996 2050 2061
61. K.C. Lounes, N. Okumura, K.A. Hogan, L. Ping, and S.T. Lord Polymerization site a function dependence on structural integrity of its nearby calcium binding site Ann. N.Y. Acad. Sci. 936 2001 205 209
62. J.A. Heit The potential role of direct thrombin inhibitors in the prevention and treatment of venous thromboembolism Chest 124 2003 40S 48S
63. J.I. Weitz A novel approach to thrombin inhibition Thromb. Res. 109 Suppl. 1 2003 S17 S22